✦ LIBER ✦
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation
✍ Scribed by Kwak, Eunice L.; Shapiro, Geoffrey I.; Cohen, Seth M.; Becerra, Carlos R.; Lenz, Heinz-Josef; Cheng, Wen-Fang; Su, Wu-Chou; Robohn, Meghan; Le Maulf, Florence; Lobmeyer, Maximilian T.; Chand, Vikram K.; Iafrate, A. John
- Book ID
- 120736173
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 360 KB
- Volume
- 119
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.